TNF-α-induced endothelium-independent vasodilation: A role for phospholipase A2-dependent ceramide signaling

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 275, Issue 5 44-5, 1998, Pages

  Johns, Douglas G ^a,b   Webb, R Clinton ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Cytokines; Sepsis; Smooth muscle relaxation; Sphingolipid signaling

Indexed keywords

CERAMIDE; CYTOKINE; PHOSPHOLIPASE A2; SPHINGOLIPID; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; ENDOTHELIUM CELL; ENDOTOXEMIA; ENZYME ACTIVATION; NONHUMAN; PRIORITY JOURNAL; RAT; SECOND MESSENGER; SEPSIS; SMOOTH MUSCLE RELAXATION; VASCULAR RING; VASCULAR SMOOTH MUSCLE; VASODILATATION;

EID: 0031755713     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1998.275.5.h1592     Document Type: Article

References (40)

1. Andrea, J. E., and M. P. Walsh. Protein kinase C of smooth muscle. Hypertension 20: 585-595, 1992.
2. 2 production and sphingomyelin metabolism. Evidence for the regulation of cyclooxygenase gene expression by sphingosine and ceramide. J. Biol. Chem. 267: 20044-20050, 1992.
3. Baudry, N., and E. Vicaut. Role of nitric oxide in effects of tumor necrosis factor-alpha on microcirculation in rat. J. Appl. Physiol. 75: 2392-2399, 1993.
4. 2 and signal transduction. J. Am. Soc. Nephrol. 3: 128-150, 1992.
5. Damas, P., J.-L. Canivet, D. DeGroote, Y. Vrindts, A. Albert, P. Franchimont, and M. Lamy. Sepsis and serum cytokine concentrations. Crit. Care Med. 25: 405-412, 1997.
6. Dobrowsky, R. T., C. Kamibayashi, M. C. Mumby, and Y. A. Hannun. Ceramide activates heterotrimeric protein phosphatase 2A. J. Biol. Chem. 268: 15523-15530, 1993.
7. Dressler, K. A., S. Mathias, and R. N. Kolesnick. Tumor necrosis factor-alpha activates the sphingomyelin signal transduction pathway in a cell-free system. Science 255: 1715-1718, 1992.
8. Ertel, W., M. H. Morrison, P. Wang, Z. F. Bah, A. Ayala, and I. H. Chaudry. The complex pattern of cytokines in sepsis: association between prostaglandins, cachectin, and interleukins. Ann. Surg. 214: 141-148, 1991.
9. Ferreri, N. R., Y. Zhao, H. Takizawa, and J. C. McGiff. Tumor necrosis factor-alpha-angiotensin interactions and regulation of blood pressure. J. Hypertens. 15: 1481-1484, 1997.
10. 2 inhibitors block catecholamine secretion and calcium uptake in cultured bovine adrenal medullary cells. Mol. Pharmacol. 23: 547-570, 1983.
11. Glembot, T. M., L. D. Britt, and M. A. Hill. Endotoxin interacts with tumor necrosis factor alpha to induce vasodilation of isolated rat skeletal muscle arterioles. Shock 5: 251-257, 1996.
12. Haller, H., J. I. Smallwood, and H. Rasmussen. Protein kinase C translocation in intact vascular smooth muscle strips. Biochem. J. 270: 375-381, 1990.
13. Harder, D. R., W. B. Campbell, and R. J. Roman. Role of cytochrome P-450 enzymes and metabolites of arachidonic acid in the control of vascular tone. J. Vasc. Res. 32: 79-92, 1995.
14. Hollenberg, S. M., R. E. Cunnion, and J. E. Parrillo. The effect of tumor necrosis factor on vascular smooth muscle. In vitro studies using rat aortic rings. Chest 100: 1133-1137, 1991.
15. 2 is necessary for tumor necrosis factor-α-induced ceramide generation in L929 cells. J. Biol. Chem. 272: 17196-17203, 1997.
16. Jayadev, S., C. M. Linardic, and Y. A. Hannun. Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor. J. Biol. Chem. 269: 5757-5763, 1994.
17. Johns, D. G., H. Osborn, and R. C. Webb. Ceramide: a novel cell signaling mechanism for vasodilation. Biochem. Biophys. Res. Commun. 237: 95-97, 1997.
18. Jones, M. J., and A. W. Murray. Evidence that ceramide selectively inhibits protein kinase C-α translocation and modulates bradykinin activation of phospholipase D. J. Biol. Chem. 270: 5007-5013, 1995.
19. Kim, M.-Y., C. Linardic, L. Obeid, and Y. Hannun. Identification of sphingomyelin turnover as an effector mechanism for the action of tumor necrosis factor alpha and gamma interferon. Specific role in cell differentiation. J. Biol. Chem. 266: 484-489, 1991.
20. Knapp, J., P. Boknik, B. Linck, H. Luss, F. U. Muller, P. Nacke, J. Neumann, U. Vahlensieck, and W. Schmitz. The effect of the protein phosphatases inhibitor cantharidin on beta-adrenoreceptor-mediated vasorelaxation. Br. J. Pharmacol. 120: 421-428, 1997.
21. Lee, J. Y., Y. A. Hannun, and L. M. Obeid. Ceramide inactivates cellular protein kinase C-alpha. J. Biol. Chem. 271: 13169-13174, 1996.
22. 2 production in vivo of the macrophage-like P3881D1 cell. Effects of manoalide, 7,7-dimethyl-5,8-eicosadienoic acid, and p-bromophenacyl bromide. J. Biol. Chem. 264: 8520-8528, 1989.
23. Mathias, S., K. A. Dressler, and R. N. Kolesnick. Characterization of a ceramide-activated protein kinase: stimulation by tumor necrosis factor alpha. Proc. Natl. Acad. Sci. USA 88: 10009-10013, 1991.
24. Mathias, S., A. Younes, C. C. Kan, I. Orlow, C. Joseph, and R. N. Kolesnick. Activation of the sphingomyelin signaling pathway in intact EL4 cells and in a cell-free system by IL-1 beta. Science 259: 519-522, 1993.
25. i and contraction caused by phorbol esters in vascular smooth muscle cells. Am. J. Physiol. 265 (Cell Physiol. 34): C1138-C1145, 1993.
26. Nakamura, T., A. Abe, K. J. Balazovich, D. Wu, S. J. Suchard, L. A. Boxer, and J. A. Shayman. Ceramide regulates oxidant release in adherent human neutrophils. J. Biol. Chem. 269: 18384-18389, 1994.
27. 2 and cyclooxygenase-2 mRNA is suppressed by glucocorticoids in human epithelial cells. Life Sci. 60: 67-78, 1997.
28. 2 by rat mesangial cells. Its contribution to arachidonic acid release and prostaglandin synthesis by cultured rat glomerular cells. J. Clin. Invest. 92: 2516-2523, 1993.
29. Preiss, J., C. R. Loomis, W. R. Bishop, R. Stein, J. E. Neidel, and R. M. Bell. Quantitative measurement of src-1,2-diacylglycerols present in platelets, hepatocytes, and ras- and sis-transformed normal rat kidney cells. J. Biol. Chem. 261: 8597-8600, 1986.
30. Preiss, J. E., C. R. Loomis, R. M. Bell, and J. E. Niedel. Quantitative measurement of sn-1,2-diacylglycerols. Methods Enzymol. 141: 294-300,1987.
31. Redman, C., J. Lefevre, and M. L. MacDonald. Inhibition of diacylglycerol kinase by the antitumor agent calphostin C. Evidence for the similarity between the active site or diacylglycerol kinase and the regulatory site of protein kinase C. Biochem. Pharmacol. 50: 235-241, 1995.
32. Rovner, A. S., R. A. Murphy, and G. K. Owens. Expression of smooth muscle and nonmuscle myosin heavy chains in cultured vascular smooth muscle cells. J. Biol. Chem. 261: 14740-14745, 1986.
33. + channels in follicle-enclosed Xenopus oocytes. Eur. J. Pharmacol. 252: 117-121, 1994.
34. Shibata, M., H. Parfenova, S. L. Zuckerman, and C. W. Leffler. Tumor necrosis factor-alpha induces pial arteriolar dilation in newborn pigs. Brain Res. Bull. 39: 241-247, 1996.
35. Stadler, E., J. H. Campbell, and G. R. Campbell. Do cultured vascular smooth muscle cells resemble those of the artery wall? If not, why not? J. Cardiovasc. Pharmacol. 14, Suppl.: S1-S8, 1989.
36. Takahashi, K., K. Ando, A. Ono, T. Shimosawa, T. Ogata, and T. Fujita. Tumor necrosis factor-alpha induces vascular hyporesponsiveness in Spraque-Dawley rats. Life Sci. 50: 1437-1444, 1992.
37. Van Veldoven, P. P., and R. M. Bell. Effect of harvesting methods, growth conditions and growth phase on diacylglycerol levels in cultured human adherent cells. Biochim. Biophys. Acta 959: 185-196, 1988.
38. 2 inhibitors of secretion of catecholamines from isolated adrenal medullary cells by suppression of cellular calcium uptake. Biochem. Pharmacol. 32: 1175-1178, 1983.
39. Wang, P., Z. F. Ba, and I. H. Chaudry. Machanism of hepatocellular dysfunction during early sepsis: key role of increased gene expression and release of proinflammatory cytokines tumor necrosis factor and interleukin-6. Arch. Surg. 132: 364-370, 1997.
40. 2-terminal kinase and the transcription factor ATF2 in the insulin-producing cell line RINm5F. J. Biol. Chem. 271: 8307-8312, 1996.